Abeta toxicity 2 [electronic resource] / Colin L. Masters.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Alzheimer's disease: ; Henry Stewart talksBiomedical & life sciences collection. Drug discovery and development in the neurosciences: Publisher: London : Henry Stewart Talks, 2011Description: 1 online resource (1 streaming video file (28 min.) : color, sound)Other title: Title from title frames: Aβ toxicity, Part II | Abeta toxicity, Part IISubject(s): Alzheimer's disease -- Chemotherapy | Alzheimer's disease -- Pathophysiology | Alzheimer's disease -- Treatment | Amyloid beta-protein | Aging -- physiology | Alzheimer Disease -- drug therapy | Alzheimer Disease -- physiopathology | Amyloid Aging | Amyloid beta-Peptides -- toxicity | Australia -- epidemiology | Biomarkers | Longditudinal StudiesOnline resources: Click here to access online | Series (Alzheimer's disease) | Series (Drug discovery and development in the neurosciences) Animated audio-visual presentation with synchronized narration.
Title from publisher's website (viewed January 2012).
Contents: The Australian imaging, biomarkers and lifestyle (aibl) flagship study of ageing -- Methodology: key outcomes -- Abeta and amyloid imaging -- The progression of AD -- Abeta and memory -- Prediction of conversion from HC to MCI/AD -- Impact of amyloid imaging in MCI patient selection for anti-amyloid therapeutic trials -- Longitudinal PiB PET follow-up -- Plasma Abeta 42 levels in the PiB-PET AIBL subset -- Relation between Abeta oligomers in blood cellular elements, cognition and PiB SUVR -- Plasma ApoE (total) levels: the AIBL study -- Biomarker discovery -- Abeta deposition.
Access restricted to subscribers.
Mode of access: World Wide Web.